Global Nucleic Acid Labeling Market Report and Forecast 2025-2034

Global Nucleic Acid Labeling Market Outlook

The global nucleic acid labeling market size was valued at USD 2.4 billion in 2024, driven by the increasing investments by key players in research and development activities across the globe. The market size is anticipated to grow at a CAGR of 8.8% during the forecast period of 2025-2034 to achieve a value of USD 5.1 billion by 2034.

Nucleic Acid Labeling: Introduction

The process of nucleic acid labeling is crucial in identifying particular DNA or RNA sequences present in unknown samples. Specific sequences of nitrogenous bases are integrated into the nucleic acid molecules before being labeled. These labels can be used to detect and purify nucleic acids with ease. Labeling of nucleic acids can be done by several methods. Some common labels used to generate nucleic acid probes include radioactive phosphates, biotin, fluorophores, and enzymes.

Global Nucleic Acid Labeling Market Analysis

The market has been witnessing significant growth in demand owing to the rising investments by major key players in the market. For example, Agilent Technologies Inc. invested about 725 million earlier this year to double the manufacturing capacity of therapeutic nucleic acids in response to the rapid growth of the market and strong demand for the company’s high-quality active pharmaceutical ingredients (API).

Additionally, the market growth is driven by the ongoing acquisitions between key players to expand the market. Novartis is a leading pharmaceutical company that may share resources and expertise to catalyze DTx Pharma's research and development efforts in the field. Such developments are expected to further propel the nucleic acid labeling market growth. This could lead to advancements in siRNA therapies for neuroscience indications, potentially expanding the applications of nucleic acid labeling technologies. This acquisition is expected to result in an expanded adoption of nucleic acid labeling methods. The adoption would be prominent especially if these technologies become integral to the development and production of siRNA therapies, bolstering the market growth.

Global Nucleic Acid Labeling Market Segmentations

Market Breakup by Product

• Reagent and Kits

• Services

Market Breakup by Technique

• PCR

• Nick Translation

• Random Primer

• In Vitro Transcription

• Reverse Transcription

• End Labelling

Market Breakup by Application

• DNA Sequencing

• Polymerase Chain Reaction

• Microarray

• In Situ Hybridization

• Other Application

Market Breakup by Region

• North America

• Europe

• Asia Pacific

• Latin America

• Middle East and Africa

Global Nucleic Acid Labeling Market Overview

The growing need for personalized medicine has opened numerous opportunities in the field of genetic medicine. This has led to the development of novel technologies, which has resulted in the rapid expansion of the market. Consequently, the global nucleic acid labeling market is experiencing significant growth, driven by the increasing focus on personalized medicine and a patient-centred approach.

The global market, based on demand, has been dominated by North America and is expected to be dominated in the forecast period as well. The market growth is significantly driven by the increasing prevalence of chronic diseases such as cancer. The market demand is also driven by the growing geriatric population, coupled with the growing demand for targeted and personalized medicine, and favourable government initiatives.

Global Nucleic Acid Labeling Market: Competitor Landscape

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:

• Thermo Fisher Scientific Inc. 

• New England Biolabs.  

• PerkinElmer Inc.  

• F. Hoffmann La-Roche AG  

• GENERAL ELECTRIC COMPANY  

• Merck KGaA  

• Enzo Biochem Inc.  

• Promega Corporation  

• Vector Laboratories  

• Agilent Technologies, Inc.  

• LubioScience GmbH  

• VWR International, LLC  

• Marker Gene Technologies, Inc.  

• Interchim  

• Helix OpCo LLC  

• Cytiva  

Please note that this only represents a partial list of companies, and the complete list has been provided in the report.

Key Highlights of the Report